CureVac

Last updated: October 24, 2025
Ingmar Hoerr, CEO
Ingmar Hoerr, CEO
Country: Germany | Funding: $2.1B (+)

Website: http://www.curevac.com/

CureVac is a biopharmaceutical company specializing in the prophylactic and therapeutic application of messenger RNA.




Competitors